Recent safety evaluations of hormone replacement therapy in Germany show a more nuanced risk-benefit profile for treating menopausal symptoms like hot flashes and sleep disturbances, shifting away from long-held anxieties sparked by a landmark 2002 United States study. Large-scale European database analyses involving nearly 100,000 women in France and Germany indicate that the timing, duration, and delivery method of hormone administration heavily influence safety outcomes.
Shifting Perceptions Since the 2002 Women’s Health Initiative
For decades, physicians and patients viewed hormone replacement therapy with extreme caution. That hesitation stemmed primarily from a major 2002 study by the Women’s Health Initiative in the United States, which linked the treatment to higher risks of breast cancer and heart attacks.